XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Liabilities (Details) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Accrued Expenses and Other Liabilities    
Accrued marketing expenses $ 999,997 $ 1,013,497
Other expenses 284,613 313,254
Accrued preclinical and clinical trial expenses 371,629 405,792
Compensation and related benefits 492,297 332,641
Accrued manufacturing expenses 11,687 97,877
Advance payments received from customers for manufacturing materials 1,839,149  
Accrued franchise tax   38,800
Accrued expenses and other current liabilities $ 3,999,372 $ 2,201,861